首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1548095

全球組織診斷市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Tissue Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球組織診斷市場需求預計將從 2023 年的 60.2 億美元達到近 122.6 億美元的市場規模，2024-2032 年研究期間複合年成長率為 8.22%。

組織診斷是癌症診斷和監測領域最先進的技術之一，也是市場成長的重要驅動力。基於組織的診斷技術能夠找出患者疾病的原因和影響。由於人們的不健康習慣，癌症病例的盛行率逐年上升，從而推動了市場的成長。癌症初始階段的診斷和治療將帶來更好的生存可能性，並且透過敦促實驗室提高診斷程序的效率以最大限度地保護患者的健康，對診斷的需求將大幅成長。已開發國家比發展中國家有足夠的健康意識，其中不同的因素是可信的，如健康素養低、經濟因素和加強監管的必要性阻礙了市場的成長。

市場動態

組織是執行特定功能並包含重要生物訊息的一堆或一系列細胞。組織樣本用於癌症診斷和監測，了解疾病的生物學背景。組織診斷的三個主要類別是免疫組織化學、蘇木精和曙紅以及原位雜合技術。蘇木精和曙紅染色與固定劑混合物配合使用效果更好，並顯示出廣泛的細胞質、細胞外基質和細胞核特徵。免疫組織化學被認為是廣泛使用的新診斷特徵之一，其中蛋白質利用抗體染色，最後的原位雜合技術識別組織中的特定核苷酸系列。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球組織診斷市場的每個細分市場進行了包容性評估。組織診斷產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

組織診斷市場報告的這一部分提供了國家和區域層級細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

依技術

免疫組織化學（儀器（玻片染色系統、組織微陣列、組織處理系統、玻片掃描器、其他產品）、耗材（抗體、試劑、試劑盒））
原位雜合技術（儀器、耗材、軟體）
初級和特殊染色
數位病理學和工作流程（全切片影像、影像分析資訊學、資訊管理系統儲存和通訊）
解剖病理學（儀器（切片機和低溫切片機、組織處理機、自動過濾器、其他產品）、消耗品（試劑和抗體、探針和試劑盒、其他）

按申請

乳癌
非小細胞肺癌
攝護腺癌
胃癌
其他癌症

按最終用途

醫院
研究實驗室
製藥機構
合約研究組織 (CRO)

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲組織診斷市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。組織診斷市場的主要參與者包括羅氏有限公司、雅培實驗室、賽默飛世爾科技公司、西門子、丹納赫、BioMeRieux SA、Qiagen、BD、Merck KGaA、GE Healthcare、BioGenex、Cell Signaling Technology Inc. .、Bio SB、DiaGenic ASA、安捷倫科技。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

依技術概述
歷史和預測數據
技術分析
免疫組織化學（儀器（玻片染色系統、組織微陣列、組織處理系統、玻片掃描器、其他產品）、耗材（抗體、試劑、試劑盒））
原位雜合技術（儀器、耗材、軟體）
初級和特殊染色
數位病理學和工作流程（全切片影像、影像分析資訊學、資訊管理系統儲存和通訊）
解剖病理學（儀器（切片機和低溫切片機、組織處理機、自動過濾器、其他產品）、消耗品（試劑和抗體、探針和試劑盒、其他）

第 6 章：全球組織診斷市場分析：依應用分類

概述：按應用
歷史和預測數據
分析：按應用
乳癌
非小細胞肺癌
攝護腺癌
胃癌
其他癌症

第 7 章：全球組織診斷市場分析：依最終用途分類

按最終用途分類的概述
歷史和預測數據
按最終用途分析
醫院
研究實驗室
製藥機構
合約研究組織 (CRO)

第 8 章：全球組織診斷市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：組織診斷公司的競爭格局

組織診斷市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
F. Hoffmann-La Roche Ltd.

公司概況
公司收入
產品
最新動態

Abbott Laboratories

公司概況
公司收入
產品
最新動態

Thermo Fisher Scientific Inc.

公司概況
公司收入
產品
最新動態

Siemens

公司概況
公司收入
產品
最新動態

Danaher

公司概況
公司收入
產品
最新動態

BioMeRieux SA

公司概況
公司收入
產品
最新動態

Qiagen

公司概況
公司收入
產品
最新動態

公司概況
公司收入
產品
最新動態

Merck KGaA

公司概況
公司收入
產品
最新動態

GE Healthcare

公司概況
公司收入
產品
最新動態

BioGenex

公司概況
公司收入
產品
最新動態

Cell Signaling Technology Inc.

公司概況
公司收入
產品
最新動態

Bio SB

公司概況
公司收入
產品
最新動態

DiaGenic ASA

公司概況
公司收入
產品
最新動態

Agilent Technologies

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11211672

The global demand for Tissue Diagnostics Market is presumed to reach the market size of nearly USD 12.26 Billion by 2032 from USD 6.02 Billion in 2023 with a CAGR of 8.22% under the study period 2024-2032.

Tissue Diagnostics is a technique which is one among the finest set in cancer diagnosis and monitoring and is the important driver in the market growth. Tissue based diagnosis technique enables to figure out the reason and impact of the disorder in a patient. Due to the unhealthy habits of people, the prevalence of cancer cases is rising over the years and so is propelling the growth of the market. Cancer diagnosis and treatment at initial stages will result in better possibilities of survival and the demand for diagnostics will register substantial growth by urging labs to improve efficiency in the diagnosis procedure to maximize health protection in sufferers. In developed countries there is adequate health consciousness than the developing countries for which different factors are credible as low health literacy, economic factors and enhancing regulatory necessities impede the market growth.

MARKET DYNAMICS

Tissue is a bunch or series of cells which execute a specific function and encompass essential biological information. Tissue specimens are used for cancer diagnosis and monitoring, where it apprehends the biological background of the disorder. The three main categories of tissue diagnosis are Immunohistochemistry, Hematoxylin and Eosin and In situ hybridization. Hematoxylin and Eosin tints work better with a mixture of fixatives and shows a wide range of cytoplasmic, extracellular matrix features and nuclear. Immunohistochemistry is known as the one among the vastly used new diagnostic traits where proteins are tinted utilizing antibodies and the last In-situ hybridization recognizes specific nucleotide series in the tissues.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Tissue Diagnostics. The growth and trends of Tissue Diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Tissue Diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

Immunohistochemistry (Instruments (Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Other Products), Consumables (Antibodies, Reagents, Kits))
In Situ Hybridization (Instruments, Consumables, Software)
Primary & Special Staining
Digital Pathology and Workflow (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication)
Anatomic Pathology (Instruments (Microtomes & Cryostat Microtomes, Tissue Processors, Automatic Strainers, Other Products), Consumables (Reagents & Antibodies, Probes & Kits, Others)

By Application

Breast Cancer
Non-small Cell Lung Cancer
Prostate Cancer
Gastric Cancer
Other Cancers

By End-use

Hospitals
Research Laboratories
Pharmaceutical Organizations
Contract Research Organizations (CROs)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Tissue Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Tissue Diagnostics market include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens, Danaher, BioMeRieux SA, Qiagen, BD, Merck KGaA, GE Healthcare, BioGenex, Cell Signaling Technology Inc., Bio SB, DiaGenic ASA, Agilent Technologies. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. TISSUE DIAGNOSTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY

5.1. Overview By Technology
5.2. Historical and Forecast Data
5.3. Analysis By Technology
5.4. Immunohistochemistry (Instruments (Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Other Products), Consumables (Antibodies, Reagents, Kits)) Historic and Forecast Sales By Regions
5.5. In Situ Hybridization (Instruments, Consumables, Software) Historic and Forecast Sales By Regions
5.6. Primary & Special Staining Historic and Forecast Sales By Regions
5.7. Digital Pathology and Workflow (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication) Historic and Forecast Sales By Regions
5.8. Anatomic Pathology (Instruments (Microtomes & Cryostat Microtomes, Tissue Processors, Automatic Strainers, Other Products), Consumables (Reagents & Antibodies, Probes & Kits, Others) Historic and Forecast Sales By Regions

6. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data
6.3. Analysis By Application
6.4. Breast Cancer Historic and Forecast Sales By Regions
6.5. Non-small Cell Lung Cancer Historic and Forecast Sales By Regions
6.6. Prostate Cancer Historic and Forecast Sales By Regions
6.7. Gastric Cancer Historic and Forecast Sales By Regions
6.8. Other Cancers Historic and Forecast Sales By Regions

7. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY END-USE

7.1. Overview By End-use
7.2. Historical and Forecast Data
7.3. Analysis By End-use
7.4. Hospitals Historic and Forecast Sales By Regions
7.5. Research Laboratories Historic and Forecast Sales By Regions
7.6. Pharmaceutical Organizations Historic and Forecast Sales By Regions
7.7. Contract Research Organizations (CROs) Historic and Forecast Sales By Regions

8. GLOBAL TISSUE DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE TISSUE DIAGNOSTICS COMPANIES

9.1. Tissue Diagnostics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF TISSUE DIAGNOSTICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. F. Hoffmann-La Roche Ltd.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Abbott Laboratories
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Thermo Fisher Scientific Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Siemens
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Danaher
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. BioMeRieux SA
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Qiagen
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. BD
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Merck KGaA
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. GE Healthcare
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. BioGenex
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. Cell Signaling Technology Inc.
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments
10.15. Bio SB
- 10.15.1 Company Overview
- 10.15.2 Company Revenue
- 10.15.3 Products
- 10.15.4 Recent Developments
10.16. DiaGenic ASA
- 10.16.1 Company Overview
- 10.16.2 Company Revenue
- 10.16.3 Products
- 10.16.4 Recent Developments
10.17. Agilent Technologies
- 10.17.1 Company Overview
- 10.17.2 Company Revenue
- 10.17.3 Products
- 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Technology (USD MN)
Immunohistochemistry (Instruments (Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Other Products), Consumables (Antibodies, Reagents, Kits)) Market Sales By Geography (USD MN)
In Situ Hybridization (Instruments, Consumables, Software) Market Sales By Geography (USD MN)
Primary & Special Staining Market Sales By Geography (USD MN)
Digital Pathology and Workflow (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication) Market Sales By Geography (USD MN)
Anatomic Pathology (Instruments (Microtomes & Cryostat Microtomes, Tissue Processors, Automatic Strainers, Other Products), Consumables (Reagents & Antibodies, Probes & Kits, Others) Market Sales By Geography (USD MN)
Analysis By Application (USD MN)
Breast Cancer Market Sales By Geography (USD MN)
Non-small Cell Lung Cancer Market Sales By Geography (USD MN)
Prostate Cancer Market Sales By Geography (USD MN)
Gastric Cancer Market Sales By Geography (USD MN)
Other Cancers Market Sales By Geography (USD MN)
Analysis By End-use (USD MN)
Hospitals Market Sales By Geography (USD MN)
Research Laboratories Market Sales By Geography (USD MN)
Pharmaceutical Organizations Market Sales By Geography (USD MN)
Contract Research Organizations (CROs) Market Sales By Geography (USD MN)
Global Tissue Diagnostics Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Tissue Diagnostics Report
Market Research Process
Market Research Methodology
Global Tissue Diagnostics Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Technology
Market Attractiveness Analysis By Application
Market Attractiveness Analysis By End-use
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Technology (USD MN)
Immunohistochemistry (Instruments (Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Other Products), Consumables (Antibodies, Reagents, Kits)) Market Sales By Geography (USD MN)
In Situ Hybridization (Instruments, Consumables, Software) Market Sales By Geography (USD MN)
Primary & Special Staining Market Sales By Geography (USD MN)
Digital Pathology and Workflow (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication) Market Sales By Geography (USD MN)
Anatomic Pathology (Instruments (Microtomes & Cryostat Microtomes, Tissue Processors, Automatic Strainers, Other Products), Consumables (Reagents & Antibodies, Probes & Kits, Others) Market Sales By Geography (USD MN)
Global Market Analysis By Application (USD MN)
Breast Cancer Market Sales By Geography (USD MN)
Non-small Cell Lung Cancer Market Sales By Geography (USD MN)
Prostate Cancer Market Sales By Geography (USD MN)
Gastric Cancer Market Sales By Geography (USD MN)
Other Cancers Market Sales By Geography (USD MN)
Global Market Analysis By End-use (USD MN)
Hospitals Market Sales By Geography (USD MN)
Research Laboratories Market Sales By Geography (USD MN)
Pharmaceutical Organizations Market Sales By Geography (USD MN)
Contract Research Organizations (CROs) Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis